Published in J Virol on September 24, 2008
High level of genetic compatibility between swine-origin H1N1 and highly pathogenic avian H5N1 influenza viruses. J Virol (2010) 2.29
Molecular determinants of adaptation of highly pathogenic avian influenza H7N7 viruses to efficient replication in the human host. J Virol (2009) 1.99
High genetic compatibility and increased pathogenicity of reassortants derived from avian H9N2 and pandemic H1N1/2009 influenza viruses. Proc Natl Acad Sci U S A (2011) 1.85
Reassortment between avian H5N1 and human H3N2 influenza viruses creates hybrid viruses with substantial virulence. Proc Natl Acad Sci U S A (2010) 1.56
Reassortment and mutation of the avian influenza virus polymerase PA subunit overcome species barriers. J Virol (2011) 1.28
Influenza virus reassortment occurs with high frequency in the absence of segment mismatch. PLoS Pathog (2013) 1.24
Nuclear import and assembly of influenza A virus RNA polymerase studied in live cells by fluorescence cross-correlation spectroscopy. J Virol (2009) 1.23
Full factorial analysis of mammalian and avian influenza polymerase subunits suggests a role of an efficient polymerase for virus adaptation. PLoS One (2009) 1.22
PB2 and hemagglutinin mutations are major determinants of host range and virulence in mouse-adapted influenza A virus. J Virol (2010) 1.21
Genomic and protein structural maps of adaptive evolution of human influenza A virus to increased virulence in the mouse. PLoS One (2011) 1.13
Virulence and genetic compatibility of polymerase reassortant viruses derived from the pandemic (H1N1) 2009 influenza virus and circulating influenza A viruses. J Virol (2011) 1.13
The contribution of PA-X to the virulence of pandemic 2009 H1N1 and highly pathogenic H5N1 avian influenza viruses. Sci Rep (2015) 1.03
Reassortment between two serologically unrelated bluetongue virus strains is flexible and can involve any genome segment. J Virol (2012) 1.02
Critical role of segment-specific packaging signals in genetic reassortment of influenza A viruses. Proc Natl Acad Sci U S A (2013) 1.00
Reassortment between seasonal H1N1 and pandemic (H1N1) 2009 influenza viruses is restricted by limited compatibility among polymerase subunits. J Virol (2011) 0.95
Viral reassortment as an information exchange between viral segments. Proc Natl Acad Sci U S A (2012) 0.90
Reassortment in segmented RNA viruses: mechanisms and outcomes. Nat Rev Microbiol (2016) 0.90
Naturally occurring mutations in the PA gene are key contributors to increased virulence of pandemic H1N1/09 influenza virus in mice. J Virol (2014) 0.89
The source of the PB1 gene in influenza vaccine reassortants selectively alters the hemagglutinin content of the resulting seed virus. J Virol (2013) 0.88
Amaryllidaceae alkaloids inhibit nuclear-to-cytoplasmic export of ribonucleoprotein (RNP) complex of highly pathogenic avian influenza virus H5N1. Influenza Other Respir Viruses (2012) 0.85
Intrasubtype reassortments cause adaptive amino acid replacements in H3N2 influenza genes. PLoS Genet (2014) 0.85
Genetics, Receptor Binding, Replication, and Mammalian Transmission of H4 Avian Influenza Viruses Isolated from Live Poultry Markets in China. J Virol (2015) 0.84
Genetic content of Influenza H3N2 vaccine seeds. PLoS Curr (2010) 0.84
Recognition of cap structure by influenza B virus RNA polymerase is less dependent on the methyl residue than recognition by influenza A virus polymerase. J Virol (2011) 0.82
Possibility of cross-species/subtype reassortments in influenza A viruses: an analysis of nonstructural protein variations. Virulence (2013) 0.82
Molecular Determinants of Virulence and Stability of a Reporter-Expressing H5N1 Influenza A Virus. J Virol (2015) 0.81
The RNA polymerase PB2 subunit of influenza A/HongKong/156/1997 (H5N1) restricts the replication of reassortant ribonucleoprotein complexes [corrected]. PLoS One (2012) 0.81
3D Molecular Modelling Study of the H7N9 RNA-Dependent RNA Polymerase as an Emerging Pharmacological Target. Influenza Res Treat (2013) 0.80
Mutations in NA that induced low pH-stability and enhanced the replication of pandemic (H1N1) 2009 influenza A virus at an early stage of the pandemic. PLoS One (2013) 0.80
Positive Selection Drives Preferred Segment Combinations during Influenza Virus Reassortment. Mol Biol Evol (2015) 0.79
Frequency of influenza H3N2 intra-subtype reassortment: attributes and implications of reassortant spread. BMC Biol (2016) 0.75
Experimental Approaches to Study Genome Packaging of Influenza A Viruses. Viruses (2016) 0.75
Avian influenza virus h3 hemagglutinin may enable high fitness of novel human virus reassortants. PLoS One (2013) 0.75
The infection of turkeys and chickens by reassortants derived from pandemic H1N1 2009 and avian H9N2 influenza viruses. Sci Rep (2015) 0.75
Influenza NA and PB1 Gene Segments Interact during the Formation of Viral Progeny: Localization of the Binding Region within the PB1 Gene. Viruses (2016) 0.75
Zoonotic Risk, Pathogenesis, and Transmission of Avian-Origin H3N2 Canine Influenza Virus. J Virol (2017) 0.75
Site-directed mutagenesis by overlap extension using the polymerase chain reaction. Gene (1989) 60.30
Molecular basis for high virulence of Hong Kong H5N1 influenza A viruses. Science (2001) 18.43
Generation of influenza A viruses entirely from cloned cDNAs. Proc Natl Acad Sci U S A (1999) 14.90
Avian-to-human transmission of the PB1 gene of influenza A viruses in the 1957 and 1968 pandemics. J Virol (1989) 10.63
A single amino acid in the PB2 gene of influenza A virus is a determinant of host range. J Virol (1993) 10.22
Establishment of multiple sublineages of H5N1 influenza virus in Asia: implications for pandemic control. Proc Natl Acad Sci U S A (2006) 9.26
Lack of transmission of H5N1 avian-human reassortant influenza viruses in a ferret model. Proc Natl Acad Sci U S A (2006) 6.35
Emergence of multiple genotypes of H5N1 avian influenza viruses in Hong Kong SAR. Proc Natl Acad Sci U S A (2002) 6.17
The polymerase complex genes contribute to the high virulence of the human H5N1 influenza virus isolate A/Vietnam/1203/04. J Exp Med (2006) 5.94
The evolution of H5N1 influenza viruses in ducks in southern China. Proc Natl Acad Sci U S A (2004) 5.87
Nuclear transport of influenza virus ribonucleoproteins: the viral matrix protein (M1) promotes export and inhibits import. Cell (1991) 4.97
A single amino acid substitution in 1918 influenza virus hemagglutinin changes receptor binding specificity. J Virol (2005) 4.71
Growth of H5N1 influenza A viruses in the upper respiratory tracts of mice. PLoS Pathog (2007) 4.49
The influenza virus NEP (NS2 protein) mediates the nuclear export of viral ribonucleoproteins. EMBO J (1998) 3.98
The mechanism by which influenza A virus nucleoprotein forms oligomers and binds RNA. Nature (2006) 3.88
The influenza virus nucleoprotein: a multifunctional RNA-binding protein pivotal to virus replication. J Gen Virol (2002) 3.77
Selective incorporation of influenza virus RNA segments into virions. Proc Natl Acad Sci U S A (2003) 3.45
Host range restriction and pathogenicity in the context of influenza pandemic. Emerg Infect Dis (2006) 3.27
The role of influenza A virus hemagglutinin residues 226 and 228 in receptor specificity and host range restriction. J Virol (1998) 3.25
Sialic acid species as a determinant of the host range of influenza A viruses. J Virol (2000) 3.10
Neuraminidase hemadsorption activity, conserved in avian influenza A viruses, does not influence viral replication in ducks. J Virol (1997) 3.00
Interaction of the influenza virus nucleoprotein with the cellular CRM1-mediated nuclear export pathway. J Virol (2001) 2.76
Contributions of two nuclear localization signals of influenza A virus nucleoprotein to viral replication. J Virol (2006) 2.60
Influenza A virus NS2 protein mediates vRNP nuclear export through NES-independent interaction with hCRM1. EMBO J (2000) 2.54
Differential sensitivity of human, avian, and equine influenza A viruses to a glycoprotein inhibitor of infection: selection of receptor specific variants. Virology (1983) 2.52
Direct sequencing of the HA gene of influenza (H3N2) virus in original clinical samples reveals sequence identity with mammalian cell-grown virus. J Virol (1990) 2.45
Genetic analysis of human H2N2 and early H3N2 influenza viruses, 1957-1972: evidence for genetic divergence and multiple reassortment events. Virology (2004) 2.44
Differences in sialic acid-galactose linkages in the chicken egg amnion and allantois influence human influenza virus receptor specificity and variant selection. J Virol (1997) 2.38
The PA subunit is required for efficient nuclear accumulation of the PB1 subunit of the influenza A virus RNA polymerase complex. J Virol (2004) 2.30
The three influenza virus polymerase (P) proteins not associated with viral nucleocapsids in the infected cell are in the form of a complex. J Virol (1987) 2.20
Two aromatic residues in the PB2 subunit of influenza A RNA polymerase are crucial for cap binding. J Biol Chem (2003) 2.15
Functional domains of the influenza A virus PB2 protein: identification of NP- and PB1-binding sites. Virology (2004) 2.10
Differential polymerase activity in avian and mammalian cells determines host range of influenza virus. J Virol (2007) 2.04
Crystal structure of the M1 protein-binding domain of the influenza A virus nuclear export protein (NEP/NS2). EMBO J (2003) 1.95
Fine mapping of the subunit binding sites of influenza virus RNA polymerase. Microbiol Immunol (2002) 1.90
Identification of two separate domains in the influenza virus PB1 protein involved in the interaction with the PB2 and PA subunits: a model for the viral RNA polymerase structure. Nucleic Acids Res (1996) 1.89
Identification of the domains of the influenza A virus M1 matrix protein required for NP binding, oligomerization and incorporation into virions. J Gen Virol (2007) 1.83
Role of the influenza virus M1 protein in nuclear export of viral ribonucleoproteins. J Virol (2000) 1.78
Molecular assembly of the influenza virus RNA polymerase: determination of the subunit-subunit contact sites. J Gen Virol (1996) 1.77
Molecular assembly of influenza virus: association of the NS2 protein with virion matrix. Virology (1993) 1.76
Two separate sequences of PB2 subunit constitute the RNA cap-binding site of influenza virus RNA polymerase. Genes Cells (1999) 1.67
Interspecies transmission of influenza viruses. Am J Respir Crit Care Med (1995) 1.51
Reassortment between human A(H3N2) viruses is an important evolutionary mechanism. Vaccine (2006) 1.32
Human influenza a viral genes responsible for the restriction of its replication in duck intestine. Virology (2002) 1.32
The molecular anatomy of influenza virus RNA polymerase. Biol Chem (1997) 1.29
Mutants and revertants of an avian influenza A virus with temperature-sensitive defects in the nucleoprotein and PB2. Virology (1991) 1.05
Mapping of functional domains on the influenza A virus RNA polymerase PB2 molecule using monoclonal antibodies. Arch Virol (2000) 1.01
In vitro and in vivo characterization of new swine-origin H1N1 influenza viruses. Nature (2009) 14.59
Experimental adaptation of an influenza H5 HA confers respiratory droplet transmission to a reassortant H5 HA/H1N1 virus in ferrets. Nature (2012) 14.17
Emergence and pandemic potential of swine-origin H1N1 influenza virus. Nature (2009) 11.34
Avian flu: influenza virus receptors in the human airway. Nature (2006) 11.28
Aberrant innate immune response in lethal infection of macaques with the 1918 influenza virus. Nature (2007) 10.40
Resistant influenza A viruses in children treated with oseltamivir: descriptive study. Lancet (2004) 8.62
Haemagglutinin mutations responsible for the binding of H5N1 influenza A viruses to human-type receptors. Nature (2006) 7.56
Avian flu: isolation of drug-resistant H5N1 virus. Nature (2005) 6.66
Enhanced virulence of influenza A viruses with the haemagglutinin of the 1918 pandemic virus. Nature (2004) 6.11
PB2 amino acid at position 627 affects replicative efficiency, but not cell tropism, of Hong Kong H5N1 influenza A viruses in mice. Virology (2004) 5.96
Influenza: lessons from past pandemics, warnings from current incidents. Nat Rev Microbiol (2005) 5.28
Properties and dissemination of H5N1 viruses isolated during an influenza outbreak in migratory waterfowl in western China. J Virol (2006) 5.26
Architecture of ribonucleoprotein complexes in influenza A virus particles. Nature (2006) 4.52
Growth of H5N1 influenza A viruses in the upper respiratory tracts of mice. PLoS Pathog (2007) 4.49
Single-reaction genomic amplification accelerates sequencing and vaccine production for classical and Swine origin human influenza a viruses. J Virol (2009) 4.20
Drosophila RNAi screen identifies host genes important for influenza virus replication. Nature (2008) 4.18
Inhibition of Lassa and Marburg virus production by tetherin. J Virol (2008) 3.98
Proposal for a revised taxonomy of the family Filoviridae: classification, names of taxa and viruses, and virus abbreviations. Arch Virol (2010) 3.77
Characterization of H7N9 influenza A viruses isolated from humans. Nature (2013) 3.71
Gain-of-function experiments on H7N9. Science (2013) 3.67
Biological and structural characterization of a host-adapting amino acid in influenza virus. PLoS Pathog (2010) 3.65
Ebola virus VP40 drives the formation of virus-like filamentous particles along with GP. J Virol (2002) 3.62
The potential for respiratory droplet-transmissible A/H5N1 influenza virus to evolve in a mammalian host. Science (2012) 3.50
Selective incorporation of influenza virus RNA segments into virions. Proc Natl Acad Sci U S A (2003) 3.45
Host range restriction and pathogenicity in the context of influenza pandemic. Emerg Infect Dis (2006) 3.27
The lipid mediator protectin D1 inhibits influenza virus replication and improves severe influenza. Cell (2013) 3.19
Emergence of influenza B viruses with reduced sensitivity to neuraminidase inhibitors. JAMA (2007) 3.00
The origins of new pandemic viruses: the acquisition of new host ranges by canine parvovirus and influenza A viruses. Annu Rev Microbiol (2005) 2.89
A single-amino-acid substitution in the NS1 protein changes the pathogenicity of H5N1 avian influenza viruses in mice. J Virol (2007) 2.80
Characterization of H5N1 influenza A viruses isolated during the 2003-2004 influenza outbreaks in Japan. Virology (2005) 2.77
Lower clinical effectiveness of oseltamivir against influenza B contrasted with influenza A infection in children. Clin Infect Dis (2006) 2.72
Hierarchy among viral RNA (vRNA) segments in their role in vRNA incorporation into influenza A virions. J Virol (2006) 2.70
Exploitation of nucleic acid packaging signals to generate a novel influenza virus-based vector stably expressing two foreign genes. J Virol (2003) 2.67
Identification of amino acids in HA and PB2 critical for the transmission of H5N1 avian influenza viruses in a mammalian host. PLoS Pathog (2009) 2.62
Contributions of two nuclear localization signals of influenza A virus nucleoprotein to viral replication. J Virol (2006) 2.60
Ebolavirus is internalized into host cells via macropinocytosis in a viral glycoprotein-dependent manner. PLoS Pathog (2010) 2.60
Reverse genetics demonstrates that proteolytic processing of the Ebola virus glycoprotein is not essential for replication in cell culture. J Virol (2002) 2.58
Human infection with highly pathogenic H5N1 influenza virus. Lancet (2008) 2.57
Enhanced expression of an alpha2,6-linked sialic acid on MDCK cells improves isolation of human influenza viruses and evaluation of their sensitivity to a neuraminidase inhibitor. J Clin Microbiol (2005) 2.55
Importance of both the coding and the segment-specific noncoding regions of the influenza A virus NS segment for its efficient incorporation into virions. J Virol (2005) 2.45
Lethal influenza virus infection in macaques is associated with early dysregulation of inflammatory related genes. PLoS Pathog (2009) 2.44
Molecular determinants of Ebola virus virulence in mice. PLoS Pathog (2006) 2.44
Selection of H5N1 influenza virus PB2 during replication in humans. J Virol (2009) 2.42
Human macrophage C-type lectin specific for galactose and N-acetylgalactosamine promotes filovirus entry. J Virol (2004) 2.34
An improved reverse genetics system for influenza A virus generation and its implications for vaccine production. Proc Natl Acad Sci U S A (2005) 2.33
Avian flu: Gain-of-function experiments on H7N9. Nature (2013) 2.32
High level of genetic compatibility between swine-origin H1N1 and highly pathogenic avian H5N1 influenza viruses. J Virol (2010) 2.29
Tyro3 family-mediated cell entry of Ebola and Marburg viruses. J Virol (2006) 2.24
Pause on avian flu transmission research. Science (2012) 2.24
Differences in cytokine production in human macrophages and in virulence in mice are attributable to the acidic polymerase protein of highly pathogenic influenza A virus subtype H5N1. J Infect Dis (2012) 2.24
Cellular networks involved in the influenza virus life cycle. Cell Host Microbe (2010) 2.23
Nedd4 regulates egress of Ebola virus-like particles from host cells. J Virol (2003) 2.19
Characterization of a human H5N1 influenza A virus isolated in 2003. J Virol (2005) 2.09
Production of novel ebola virus-like particles from cDNAs: an alternative to ebola virus generation by reverse genetics. J Virol (2004) 2.09
The cytoplasmic tail of the influenza A virus M2 protein plays a role in viral assembly. J Virol (2006) 2.07
An infectious disease of ducks caused by a newly emerged Tembusu virus strain in mainland China. Virology (2011) 2.05
A critical role for the sphingosine analog AAL-R in dampening the cytokine response during influenza virus infection. Proc Natl Acad Sci U S A (2009) 2.04
Cellular factors required for Lassa virus budding. J Virol (2006) 2.02
Ebola virus VP40 late domains are not essential for viral replication in cell culture. J Virol (2005) 1.97
The pathogenesis of influenza virus infections: the contributions of virus and host factors. Curr Opin Immunol (2011) 1.95
High frequency of resistant viruses harboring different mutations in amantadine-treated children with influenza. J Infect Dis (2003) 1.89
Antibody-dependent enhancement of viral infection: molecular mechanisms and in vivo implications. Rev Med Virol (2003) 1.88
The role of receptor binding specificity in interspecies transmission of influenza viruses. Curr Opin Virol (2012) 1.84
A shared structural solution for neutralizing ebolaviruses. Nat Struct Mol Biol (2011) 1.84
Antibodies are necessary for rVSV/ZEBOV-GP-mediated protection against lethal Ebola virus challenge in nonhuman primates. Proc Natl Acad Sci U S A (2013) 1.81